RecruitingNot Applicable

MINIject Global Long-Term Follow-up Study

Colombia, France, Germany300 participantsStarted 2020-08-05

Plain-language summary

The study will assess the long-term (up to 5 years) safety and performance in patients with open-angle glaucoma uncontrolled by topical hypotensive medications who had previously been implanted with a MINIject glaucoma implant.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient who received a MINIject glaucoma implant within a prior clinical study * Patient continues to have MINIject implanted at the point of enrolment * Patient must provide written informed consent to participate Exclusion Criteria: * Individuals under tutorship or trusteeship * Patient who is unwilling to return to the study visits and undergo study assessments, as required by clinical study protocol

What they're measuring

Proportion of patients with serious device-related adverse event in study eye

Timeframe: 5 years post-implantation

Trial details

NCT IDNCT04524416

SponsoriSTAR Medical

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-12

Contact for this trial

Esma Islamaj, PhD

+32 10 77 12 52 esma.islamaj@istarmed.com

View on ClinicalTrials.gov More Open Angle Glaucoma trials